4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-15-000046
$REGNCIK 0000872589operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 6:15 PM ET
Size
27.9 KB
Accession
0001237899-15-000046
Insider Transaction Report
Form 4
GILMAN ALFRED G
Director
Transactions
- Sale
Common Stock
2015-08-06$593.00/sh−62$36,766→ 8,912 total - Exercise/Conversion
Common Stock
2015-08-06$57.11/sh+5,000$285,550→ 13,912 total - Sale
Common Stock
2015-08-06$582.15/sh−300$174,645→ 13,612 total - Sale
Common Stock
2015-08-06$583.43/sh−400$233,372→ 13,212 total - Sale
Common Stock
2015-08-06$584.52/sh−800$467,616→ 12,412 total - Sale
Common Stock
2015-08-06$585.35/sh−800$468,280→ 11,612 total - Sale
Common Stock
2015-08-06$586.49/sh−200$117,298→ 11,412 total - Sale
Common Stock
2015-08-06$587.55/sh−400$235,020→ 11,012 total - Sale
Common Stock
2015-08-06$588.33/sh−400$235,332→ 10,612 total - Sale
Common Stock
2015-08-06$589.73/sh−400$235,892→ 10,212 total - Sale
Common Stock
2015-08-06$590.37/sh−900$531,333→ 9,312 total - Sale
Common Stock
2015-08-06$591.39/sh−200$118,278→ 9,112 total - Sale
Common Stock
2015-08-06$592.53/sh−138$81,769→ 8,974 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-08-06−5,000→ 0 totalExercise: $57.11Exp: 2022-01-03→ Common Stock (5,000 underlying)
Footnotes (12)
- [F1]Represents volume-weighted average price of sales of 300 shares of Company stock on August 6, 2015 at prices ranging from $582.05 to $582.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F10]Represents volume-weighted average price of sales of 200 shares of Company stock on August 6, 2015 at prices ranging from $591.02 to $591.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F11]Represents volume-weighted average price of sales of 138 shares of Company stock on August 6, 2015 at prices ranging from $592.40 to $592.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F12]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
- [F2]Represents volume-weighted average price of sales of 400 shares of Company stock on August 6, 2015 at prices ranging from $583.01 to $583.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F3]Represents volume-weighted average price of sales of 800 shares of Company stock on August 6, 2015 at prices ranging from $584.10 to $584.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F4]Represents volume-weighted average price of sales of 800 shares of Company stock on August 6, 2015 at prices ranging from $585.08 to $585.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F5]Represents volume-weighted average price of sales of 200 shares of Company stock on August 6, 2015 at prices ranging from $586.26 to $586.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F6]Represents volume-weighted average price of sales of 400 shares of Company stock on August 6, 2015 at prices ranging from $587.14 to $587.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F7]Represents volume-weighted average price of sales of 400 shares of Company stock on August 6, 2015 at prices ranging from $588.02 to $588.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F8]Represents volume-weighted average price of sales of 400 shares of Company stock on August 6, 2015 at prices ranging from $589.44 to $589.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
- [F9]Represents volume-weighted average price of sales of 900 shares of Company stock on August 6, 2015 at prices ranging from $590.01 to $590.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 6, 2015 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 6:15 PM ET
- Size
- 27.9 KB